← Back to Screener
3M Company (MMM)
Price$151.40
Favorite Metrics
Price vs S&P 500 (26W)-4.85%
Price vs S&P 500 (4W)-0.04%
Market Capitalization$80.03B
P/E Ratio (Annual)24.63x
Indicated Dividend Yield (Annual)2.02%
All Metrics
P/CF (Annual)35.41x
Book Value / Share (Quarterly)$8.95
P/TBV (Annual)26.71x
Indicated Dividend (Annual)$2.92
Revenue Growth (3Y)-1.57%
Cash Flow / Share (Quarterly)$2.55
Payout Ratio (TTM)45.66%
Price vs S&P 500 (YTD)-7.60%
Gross Margin (TTM)39.92%
Net Profit Margin (TTM)13.03%
EPS (TTM)$6.00
10-Day Avg Trading Volume2.86M
EPS Excl Extra (TTM)$6.00
Revenue Growth (5Y)-4.97%
EPS (Annual)$6.00
Dividend / Share (Annual)$3.63
ROI (Annual)18.73%
Gross Margin (Annual)39.91%
Net Profit Margin (5Y Avg)8.08%
Cash / Share (Quarterly)$11.19
P/E Basic Excl Extra (TTM)24.63x
Revenue Growth QoQ (YoY)2.05%
EPS Growth (5Y)-8.50%
P/E Normalized (Annual)24.63x
ROA (Last FY)8.61%
Revenue Growth TTM (YoY)1.52%
EBITD / Share (TTM)$9.97
ROE (5Y Avg)22.03%
Operating Margin (TTM)18.55%
Cash Flow / Share (Annual)$2.55
P/B Ratio16.86x
P/B Ratio (Quarterly)17.92x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)3.50x
Net Interest Coverage (TTM)-15.31x
ROA (TTM)8.48%
EPS Growth QoQ (YoY)-19.70%
EV / EBITDA (TTM)16.19x
EPS Incl Extra (Annual)$6.00
Current Ratio (Annual)1.71x
Quick Ratio (Quarterly)1.29x
3-Month Avg Trading Volume3.66M
52-Week Price Return18.47%
EV / Free Cash Flow (Annual)64.74x
P/E Incl Extra (TTM)24.63x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$6.59
P/S Ratio (Annual)3.21x
Asset Turnover (Annual)0.66x
52-Week High$177.41
Operating Margin (5Y Avg)6.45%
EPS Excl Extra (Annual)$6.00
CapEx CAGR (5Y)-9.52%
Tangible BV CAGR (5Y)-6.50%
26-Week Price Return3.90%
Quick Ratio (Annual)1.29x
13-Week Price Return-9.08%
Total Debt / Equity (Annual)2.65x
Current Ratio (Quarterly)1.71x
Enterprise Value$87,399.07
Revenue / Share Growth (5Y)-3.57%
Asset Turnover (TTM)0.65x
Book Value / Share Growth (5Y)-16.66%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)4.07x
Pretax Margin (Annual)16.89%
Cash / Share (Annual)$11.19
3-Month Return Std Dev31.67%
Gross Margin (5Y Avg)41.40%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)-14.45%
EBITDA Interim CAGR (5Y)-20.35%
ROE (Last FY)68.46%
Net Interest Coverage (Annual)4.70x
EPS Basic Excl Extra (Annual)$6.00
P/FCF (TTM)28.31x
Receivables Turnover (TTM)7.42x
EV / Free Cash Flow (TTM)64.74x
Total Debt / Equity (Quarterly)2.65x
EPS Incl Extra (TTM)$6.00
Receivables Turnover (Annual)7.42x
ROI (TTM)18.58%
Dividend Growth Rate (5Y)-8.82%
P/S Ratio (TTM)3.21x
Pretax Margin (5Y Avg)5.43%
Revenue / Share (Annual)$46.09
Tangible BV / Share (Annual)$4.88
Forward P/E17.49x
Free OCF CAGR (5Y)-27.22%
Price vs S&P 500 (52W)-16.63%
P/E Ratio (TTM)24.63x
EPS Growth TTM (YoY)-20.58%
Year-to-Date Return-3.47%
5-Day Price Return1.15%
EPS Normalized (Annual)$6.00
ROA (5Y Avg)6.05%
Net Profit Margin (Annual)13.03%
Month-to-Date Return6.42%
Cash Flow / Share (TTM)$-9.92
EBITD / Share (Annual)$7.78
EPS Growth (3Y)-16.13%
Operating Margin (Annual)18.55%
LT Debt / Equity (Annual)2.30x
P/CF (TTM)35.41x
ROI (5Y Avg)9.38%
P/E Excl Extra (TTM)24.63x
LT Debt / Equity (Quarterly)2.30x
EPS Basic Excl Extra (TTM)$6.00
P/TBV (Quarterly)23.55x
Payout Ratio (Annual)47.50%
P/B Ratio (Annual)17.92x
Dividend / Share (TTM)$2.89
Inventory Turnover (TTM)4.07x
Pretax Margin (TTM)16.89%
Book Value / Share (Annual)$8.95
Price vs S&P 500 (13W)-11.95%
Net Margin Growth (5Y)-5.10%
Dividend Yield (TTM)1.94%
Beta1.08x
P/FCF (Annual)59.28x
Revenue / Share (TTM)$46.29
ROE (TTM)71.71%
52-Week Low$124.65
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.78
3.71
3.71
3.71
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
GMEDGLOBUS MEDICAL INC | 4.37x | 30.08% | 67.41% | 20.33% | $96.82 |
About
3M is a multinational industrial conglomerate with a diversified product portfolio across safety and industrial solutions (44% of revenue), transportation and electronics (36%), and consumer goods (20%). The company leverages proprietary technologies and strong R&D capabilities to develop innovative products across thousands of offerings worldwide. With operations spanning the globe, 3M generates nearly half its revenue internationally. In 2024, the company separated its healthcare business into an independent entity, Solventum, to focus on its core industrial and consumer segments.